195 related articles for article (PubMed ID: 32536998)
21. MYD88
Ferrante M; Furlan D; Zibellini S; Borriero M; Candido C; Sahnane N; Uccella S; Genuardi E; Alessandria B; Bianchi B; Mora B; Grimaldi D; Defrancesco I; Jiménez C; Cavallo F; Ferrero D; Dogliotti I; Merli M; Varettoni M; Ferrero S; Drandi D
Diagnostics (Basel); 2021 Apr; 11(5):. PubMed ID: 33926007
[TBL] [Abstract][Full Text] [Related]
22. Detection of MYD88 L265P and WHIM-like CXCR4 mutation in patients with IgM monoclonal gammopathy related disease.
Cao XX; Meng Q; Cai H; He TH; Zhang CL; Su W; Sun J; Li Y; Xu W; Zhou DB; Li J
Ann Hematol; 2017 Jun; 96(6):971-976. PubMed ID: 28280994
[TBL] [Abstract][Full Text] [Related]
23. Clinical significance of MYD88 non-L265P mutations in diffuse large B-cell lymphoma.
Xie J; Shen X; Shi Q; Yi H; Ouyang B; Zhang Z; Gu Y; Dong L
Hematol Oncol; 2022 Dec; 40(5):885-893. PubMed ID: 36053490
[TBL] [Abstract][Full Text] [Related]
24. Combining MYD88 L265P mutation detection and clonality determination on CSF cellular and cell-free DNA improves diagnosis of primary CNS lymphoma.
Bravetti C; Degaud M; Armand M; Sourdeau E; Mokhtari K; Maloum K; Osman J; Verrier P; Houillier C; Roos-Weil D; Soussain C; Choquet S; Hoang-Xuan K; Le Garff-Tavernier M; Denis JA; Davi F
Br J Haematol; 2023 Jun; 201(6):1088-1096. PubMed ID: 36941788
[TBL] [Abstract][Full Text] [Related]
25. MYD88 L265P MUTATION DETECTION IN THE AQUEOUS HUMOR OF PATIENTS WITH VITREORETINAL LYMPHOMA.
Miserocchi E; Ferreri AJM; Giuffrè C; Cangi MG; Francaviglia I; Calimeri T; Ponzoni M; Pecciarini L; Bandello FM; Modorati GM
Retina; 2019 Apr; 39(4):679-684. PubMed ID: 30204732
[TBL] [Abstract][Full Text] [Related]
26. Clinicopathological features of 49 primary gastrointestinal diffuse large B-cell lymphoma cases; comparison with location, cell-of-origin, and frequency of MYD88 L265P.
Nagakita K; Takata K; Taniguchi K; Miyata-Takata T; Sato Y; Tari A; Ohnishi N; Noujima-Harada M; Omote S; Nakamura N; Iwamuro M; Maeda Y; Okada H; Tanimoto M; Yoshino T
Pathol Int; 2016 Aug; 66(8):444-52. PubMed ID: 27439595
[TBL] [Abstract][Full Text] [Related]
27. Highly sensitive
Drandi D; Genuardi E; Dogliotti I; Ferrante M; Jiménez C; Guerrini F; Schirico ML; Mantoan B; Muccio V; Lia G; Zaccaria GM; Omedè P; Passera R; Orsucci L; Benevolo G; Cavallo F; Galimberti S; Sanz RG; Boccadoro M; Ladetto M; Ferrero S
Haematologica; 2018 Jun; 103(6):1029-1037. PubMed ID: 29567768
[TBL] [Abstract][Full Text] [Related]
28. Development of high-resolution melting analysis for the detection of the MYD88 L265P mutation.
Wang CZ; Lin J; Qian J; Shao R; Xue D; Qian W; Xiao GF; Deng ZQ; Yang J; Li Y; Chen XX
Clin Biochem; 2013 Mar; 46(4-5):385-7. PubMed ID: 23178471
[TBL] [Abstract][Full Text] [Related]
29. Clinicopathologic significance of MYD88 L265P mutation in diffuse large B-cell lymphoma: a meta-analysis.
Lee JH; Jeong H; Choi JW; Oh H; Kim YS
Sci Rep; 2017 May; 7(1):1785. PubMed ID: 28496180
[TBL] [Abstract][Full Text] [Related]
30. Detection of MYD88 L265P in patients with lymphoplasmacytic lymphoma/Waldenstrom macroglobulinemia and other B-cell non-Hodgkin lymphomas.
Shin SY; Lee ST; Kim HY; Park CH; Kim HJ; Kim JW; Kim SJ; Kim WS; Kim SH
Blood Res; 2016 Sep; 51(3):181-186. PubMed ID: 27722129
[TBL] [Abstract][Full Text] [Related]
31. Frequent MYD88 L265P and CD79B Mutations in Primary Breast Diffuse Large B-Cell Lymphoma.
Taniguchi K; Takata K; Chuang SS; Miyata-Takata T; Sato Y; Satou A; Hashimoto Y; Tamura M; Nagakita K; Ohnishi N; Noujima-Harada M; Tabata T; Kikuti YY; Maeda Y; Nakamura N; Tanimoto M; Yoshino T
Am J Surg Pathol; 2016 Mar; 40(3):324-34. PubMed ID: 26752547
[TBL] [Abstract][Full Text] [Related]
32. CD79B mutations in primary vitreoretinal lymphoma: Diagnostic and prognostic potential.
Yonese I; Takase H; Yoshimori M; Onozawa E; Tsuzura A; Miki T; Mochizuki M; Miura O; Arai A
Eur J Haematol; 2019 Feb; 102(2):191-196. PubMed ID: 30390359
[TBL] [Abstract][Full Text] [Related]
33. MYD88 L265P Mutations, But No Other Variants, Identify a Subpopulation of DLBCL Patients of Activated B-cell Origin, Extranodal Involvement, and Poor Outcome.
Rovira J; Karube K; Valera A; Colomer D; Enjuanes A; Colomo L; Martínez-Trillos A; Giné E; Dlouhy I; Magnano L; Delgado J; Martínez A; Villamor N; Campo E; López-Guillermo A
Clin Cancer Res; 2016 Jun; 22(11):2755-64. PubMed ID: 26792260
[TBL] [Abstract][Full Text] [Related]
34. Biological and Clinical Relevance of Associated Genomic Alterations in MYD88 L265P and non-L265P-Mutated Diffuse Large B-Cell Lymphoma: Analysis of 361 Cases.
Dubois S; Viailly PJ; Bohers E; Bertrand P; Ruminy P; Marchand V; Maingonnat C; Mareschal S; Picquenot JM; Penther D; Jais JP; Tesson B; Peyrouze P; Figeac M; Desmots F; Fest T; Haioun C; Lamy T; Copie-Bergman C; Fabiani B; Delarue R; Peyrade F; André M; Ketterer N; Leroy K; Salles G; Molina TJ; Tilly H; Jardin F
Clin Cancer Res; 2017 May; 23(9):2232-2244. PubMed ID: 27923841
[No Abstract] [Full Text] [Related]
35. Significance of MYD88 L265P Mutation Status in the Subclassification of Low-Grade B-Cell Lymphoma/Leukemia.
Insuasti-Beltran G; Gale JM; Wilson CS; Foucar K; Czuchlewski DR
Arch Pathol Lab Med; 2015 Aug; 139(8):1035-41. PubMed ID: 26230596
[TBL] [Abstract][Full Text] [Related]
36. High frequency and prognostic value of
Yu S; Luo H; Pan M; Palomino LA; Song X; Wu P; Huang JM; Zhang Z
Oncol Lett; 2018 Feb; 15(2):1707-1715. PubMed ID: 29403563
[TBL] [Abstract][Full Text] [Related]
37. MYD88 L265P mutation in primary central nervous system lymphoma is associated with better survival: A single-center experience.
Curran OE; Poon MTC; Gilroy L; Torgersen A; Smith C; Al-Qsous W
Neurooncol Adv; 2021; 3(1):vdab090. PubMed ID: 34377990
[TBL] [Abstract][Full Text] [Related]
38. Tumor and Cerebrospinal Fluid microRNAs in Primary Central Nervous System Lymphomas.
Zajdel M; Rymkiewicz G; Sromek M; Cieslikowska M; Swoboda P; Kulinczak M; Goryca K; Bystydzienski Z; Blachnio K; Ostrowska B; Borysiuk A; Druzd-Sitek A; Walewski J; Chechlinska M; Siwicki JK
Cancers (Basel); 2019 Oct; 11(11):. PubMed ID: 31731456
[TBL] [Abstract][Full Text] [Related]
39. Multiplex Droplet Digital PCR Quantification of Recurrent Somatic Mutations in Diffuse Large B-Cell and Follicular Lymphoma.
Alcaide M; Yu S; Bushell K; Fornika D; Nielsen JS; Nelson BH; Mann KK; Assouline S; Johnson NA; Morin RD
Clin Chem; 2016 Sep; 62(9):1238-47. PubMed ID: 27440511
[TBL] [Abstract][Full Text] [Related]
40. Circulating cell-free DNA and IL-10 from cerebrospinal fluids aid primary vitreoretinal lymphoma diagnosis.
Zhuang Z; Zhang Y; Zhang X; Zhang M; Zou D; Zhang L; Jia C; Zhang W
Front Oncol; 2022; 12():955080. PubMed ID: 36059608
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
